Looking Into Emergent BioSolutions's Recent Short Interest

Emergent BioSolutions's (NYSE:EBS) short percent of float has fallen 23.58% since its last report. The company recently reported that it has 5.89 million shares sold short, which is 13.77% of all regu

BenzingaMay 8 10:15 ET

Express News | NYSE Order Imbalance 57250.0 Shares on Buy Side

ReutersMay 6 15:50 ET

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention.Investors are constantly o

BenzingaMay 3 10:51 ET

Emergent BioSolutions Reports Blockbuster Q1 Results, Raises Guidance: What's Going On With The Stock?

Emergent BioSolutions, Inc. (NYSE:EBS) shares surged higher Thursday after the company announced operational changes to stabilize its financial position and reported first-quarter financial results.Th

BenzingaMay 2 16:55 ET

Emergent BioSolutions EBS; Accuray ARAY Analyst

BioPharmCatalystMay 2 16:06 ET

Express News | NYSE Order Imbalance 155860.0 Shares on Buy Side

ReutersMay 2 15:50 ET